Recent identifiers of high-risk patients include chromosomal abnormalities, immunoglobulin heavy chain variable gene, ZAP70, CD38, b2 microglobulin and lactate dehydrogenase (LDH), and CLL upregulated gene 1 (CLLU1) expression [2]. The gene discussed is CLLU1; the disease is B-cell chronic lymphocytic leukemia.